Research highlights

Radiomics and machine learning for response prediction in Diffuse Large B-Cell Lymphoma patients using advanced medical imaging technologies Radiomics technology extracts a large number of features from medical imaging to predict treatment response.

Ongoing

Causes of twinning in humans What causes women to have twin (or higher-order multiple birth) pregnancies? To answer we need to distinguish between identical and fraternal twin pregnancies.

Ongoing

Single domain antibody targeting of the CD1d monomorphic antigen-presenting molecule induces potent anti-tumour activity Camelid-derived single domain antibodies (VHH)5 specific for the human MHC class I-like molecule CD1d can modulate the function of CD1d-restricted T cell populations.

Ongoing

Germline biomarkers of melanoma immunotherapy: an international consortium Biomarkers that predict immunotherapy treatment success or risk of toxicity are urgently needed to increase the clinical benefit for metastatic melanoma patients.

Ongoing

Daily electrical stimulation to prevent recurring pressure ulcers in patients with a spinal cord injury This project compares usual care with daily electrical stimulation to prevent recurrent PUs (Pressure Ulcers) in people with spinal cord injuries.

Ongoing

Training Network for Optimizing Adoptive T cell Therapy of Cancer (T-OP) The clinical implementation of immunotherapeutics has established T cells as efficient anti-cancer weapons if targeted by specific drugs.

Ongoing

Developing immunotherapy for atherosclerosis: a challenging adventure Immunotherapy is integrated in oncology treatment, but the exploitation in cardiovascular disease is in its infancy. Lowering inflammation is an important strategy for combating cardiovascular disease.

Ongoing

Training Network for Optimizing Adoptive T Cell Therapy of Cancer (T-OP) The clinical implementation of immunotherapeutics has established T cells as efficient anti-cancer weapons.

Ongoing

Major breakthroughs in lymphoma and leukemia therapy: Ibrutinib and Venetoclax Important contributions are made to preclinical and clinical investigations involving targeted therapies for lymphoma and leukemia patients: from bench to bedside, and back!

Completed

Our research highlights